BNP Paribas Financial Markets’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-10
| Closed | -$6 | – | 4224 |
|
|
2020
Q4 | $6 | Hold |
10
| – | – | ﹤0.01% | 4130 |
|
|
2020
Q3 | $5 | Sell |
10
-250
| -96% | -$170 | ﹤0.01% | 4190 |
|
|
2020
Q2 | $178 | Hold |
260
| – | – | ﹤0.01% | 4211 |
|
|
2020
Q1 | $195 | Hold |
260
| – | – | ﹤0.01% | 4183 |
|
|
2019
Q4 | $393 | Sell |
260
-5,264
| -95% | -$7.9K | ﹤0.01% | 4270 |
|
|
2019
Q3 | $8.18K | Hold |
5,524
| – | – | ﹤0.01% | 4194 |
|
|
2019
Q2 | $7.13K | Sell |
5,524
-4,574
| -45% | -$8.41K | ﹤0.01% | 4181 |
|
|
2019
Q1 | $26.4K | Buy |
10,098
+9,552
| +1,749% | +$22.4K | ﹤0.01% | 3821 |
|
|
2018
Q4 | $901 | Sell |
546
-426
| -44% | -$1.2K | ﹤0.01% | 3934 |
|
|
2018
Q3 | $4.71K | Hold |
972
| – | – | ﹤0.01% | 4085 |
|
|
2018
Q2 | $6.08K | Sell |
972
-4,454
| -82% | -$33.2K | ﹤0.01% | 4008 |
|
|
2018
Q1 | $45K | Buy |
5,426
+223
| +4% | +$2.13K | ﹤0.01% | 3615 |
|
|
2017
Q4 | $53.1K | Buy |
5,203
+3,717
| +250% | +$35.7K | ﹤0.01% | 3633 |
|
|
2017
Q3 | $13.6K | Sell |
1,486
-136
| -8% | -$1.03K | ﹤0.01% | 3782 |
|
|
2017
Q2 | $11.8K | Buy |
1,622
+1,549
| +2,122% | +$11.7K | ﹤0.01% | 3898 |
|
|
2017
Q1 | $526 | Sell |
73
-616
| -89% | -$3.82K | ﹤0.01% | 3842 |
|
|
2016
Q4 | $4.03K | Sell |
689
-150
| -18% | -$1.01K | ﹤0.01% | 3779 |
|
|
2016
Q3 | $5.52K | Buy |
839
+291
| +53% | +$2.31K | ﹤0.01% | 3368 |
|
|
2016
Q2 | $5.08K | Buy |
548
+528
| +2,640% | +$5.04K | ﹤0.01% | 3262 |
|
|
2016
Q1 | $216 | Sell |
20
-477
| -96% | -$5.03K | ﹤0.01% | 2595 |
|
|
2015
Q4 | $7.12K | Sell |
497
-527
| -51% | -$7.95K | ﹤0.01% | 3302 |
|
|
2015
Q3 | $21.5K | Buy |
+1,024
| New | +$22.6K | ﹤0.01% | 3283 |
|
BNP Paribas Financial Markets's NEOS Position: Q1 2021 in Review
BNP Paribas Financial Markets sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 10 shares — an estimated $6 sold.
BNP Paribas Financial Markets first reported a position in NEOS in Q3 2015 and held it in 22 quarters. The position peaked at $53.1K in Q4 2017. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.
- BNP Paribas Financial Markets reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
- BNP Paribas Financial Markets sold 10 Neos Therapeutics, Inc shares in Q1 2021, an estimated $6.
- BNP Paribas Financial Markets first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 22 quarters.
- BNP Paribas Financial Markets's Neos Therapeutics, Inc position peaked at $53.1K in Q4 2017.
- 0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2021, filed 7 May 2021.